Narrow scope
One market, one treatment line. The wider the scope, the lower the measurement value.
Medical-tourism agency service
The 90-day plan turns strategy into weekly work. The first month is infrastructure and compliance, the second launch and testing, the third measurement and correction. Every step has an owner and an acceptance criterion, so progress ties to completed work rather than the impression of meetings.
Three months is a learning period in medical tourism, not a result. What it is meant to produce is not a jump in patient numbers but visibility into which message resonates in which market, where the enquiry stalls and at which step the team slows down.

The first month goes to building the ground the visibility will stand on, not to raising visibility. Institutional identity pages, treatment information pages, privacy and data-processing texts, the enquiry form and the first-response flow are completed in this period.
The informational language framework is written in the same window and the internal approval chain is established. Skip this and every piece of content produced in month two waits in the legal queue while the calendar slips.
Month two goes live for one selected market and one treatment line. Keeping scope narrow is deliberate: testing three markets simultaneously makes it impossible to tell which variable worked.
Content, search visibility and any advertising components run together while the enquiry flow meets real traffic. What is asked of the team is not a campaign but that every incoming enquiry lands in the same record and is answered within the same window.
Indicators watched in month two
Month three is reserved for reading the output of the first two, not for opening new work. Which page produced enquiries, which question went unanswered, at which step the loss occurred — all collected in one review document.
At period end one of three decisions is taken: deepen in the same market, open a second market, or go back and strengthen the infrastructure. Taking that decision on evidence is the plan's real output.
One market, one treatment line. The wider the scope, the lower the measurement value.
A completed output every week; progress visible at week end rather than month end.
Every step has a pre-written criterion for being counted as done.
Working sequence
Institutional identity, authorisation and transparency pages; data and privacy texts.
Treatment information pages, enquiry form, first-response flow and approval chain.
Launch in the selected market; content, visibility and enquiry flow meet real traffic.
Indicator reading, content and flow corrections, closing unanswered questions.
Review document and a three-way decision: deepen, expand or strengthen.
Frequently asked questions
We do not commit to a number. Three months is the minimum period for measuring which message resonates in which market; patient volume depends on capacity, price and competitive conditions.
No. Month one is entirely infrastructure. Advertising can start from month two, but we postpone spend if the enquiry flow is not ready.
Typically one hour of review per week plus around two hours for approvals. Where the approval chain is undefined this can triple.
Technically yes, but we advise against it. A market change breaks the measurement chain; if a change is necessary, closing the period and starting a new 90 days is healthier.
No. The plan is the implementation calendar of the strategy. Without a strategy the plan is only a task list and the question of why remains unanswered.
The engagement does not have to end there. Period end is a decision point; the institution can continue, change scope or pause. Every option is recorded with its written rationale.
Next step
Share your current position and we will draw up a realistic start calendar.